| Year |
Title |
Altmetric |
| 2018
|
Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates /631/326/596 /692/699/255/1901 /82/58 /38/91 /82/80 article.
Scientific Reports.
8.
2018
|
|
| 2018
|
Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV.
PLoS One.
13.
2018
|
|
| 2018
|
ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling.
Current Eye Research.
43:135-146.
2018
|
|
| 2018
|
Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Journal of Lipid Research.
59:2075-2083.
2018
|
|
| 2018
|
The apolipoprotein e mimetic peptide AEM-2 attenuates mitochondrial injury and apoptosis in human THP-1 macrophages.
Current topics in peptide & protein research.
19:15-25.
2018
|
|
| 2016
|
Apolipoprotein mimetic peptides as modulators of lipoprotein function
2016
|
|
| 2015
|
Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
Journal of Medical Primatology.
44:286-295.
2015
|
|
| 2015
|
Rectal application of a highly osmolar personal lubricant in a macaque model induces acute cytotoxicity but does not increase risk of SHIV infection.
PLoS One.
10.
2015
|
|
| 2014
|
Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
Innate Immunity.
20:867-880.
2014
|
|
| 2014
|
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review.
Journal of Lipid Research.
55:2007-2021.
2014
|
|
| 2014
|
Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection.
Journal of Medical Primatology.
43:349-359.
2014
|
|
| 2014
|
Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques.
Journal of Medical Primatology.
43:370-373.
2014
|
|
| 2014
|
Pharmacokinetic and safety analyses of tenofovir and tenofovir- emtricitabine vaginal tablets in pigtailed macaques.
Antimicrobial Agents and Chemotherapy.
58:2665-2674.
2014
|
|
| 2013
|
Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.
Biochemical and Biophysical Research Communications.
436:705-710.
2013
|
|
| 2013
|
Recent progress in the development of apoA-I and apoE mimetic therapies.
Clinical Lipidology.
8:265-268.
2013
|
|
| 2013
|
Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
Atherosclerosis.
227:58-64.
2013
|
|
| 2013
|
In vivo and in vitro effects of an apolipoprotein E mimetic peptide on amyloid-β pathology.
Journal of Alzheimer's Disease.
36:335-347.
2013
|
|
| 2013
|
Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse.
Redox Biology.
1:381-386.
2013
|
|
| 2012
|
Deletion of specific immune-modulatory genes from modified vaccinia virus ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.
Journal of Virology.
86:12605-12615.
2012
|
|
| 2012
|
Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Atherosclerosis.
224:326-331.
2012
|
|
| 2012
|
Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.
Journal of Lipid Research.
53:849-858.
2012
|
|
| 2011
|
Apolipoprotein E mimetics and cholesterol-lowering properties.
American Journal of Cardiovascular Drugs.
11:371-381.
2011
|
|
| 2011
|
Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators.
Journal of Bone and Mineral Research.
26:1913-1925.
2011
|
|
| 2011
|
Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques.
PLoS Pathogens.
7.
2011
|
|
| 2011
|
Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.
Molecular Therapy.
19:417-426.
2011
|
|
| 2010
|
ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
Advances in Experimental Medicine and Biology.
660:1-4.
2010
|
|
| 2010
|
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
Journal of Lipid Research.
51:3491-3499.
2010
|
|
| 2010
|
Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
Atherosclerosis.
213:449-457.
2010
|
|
| 2010
|
Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2.
Atherosclerosis.
208:134-141.
2010
|
|
| 2009
|
Selective removal of stratum corneum by microdermabrasion to increase skin permeability.
European Journal of Pharmaceutical Sciences.
38:95-103.
2009
|
|
| 2009
|
Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.
Journal of Virology.
83:8182-8190.
2009
|
|
| 2009
|
Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Journal of Immunology.
183:706-717.
2009
|
|
| 2009
|
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
Neurobiology of Disease.
34:525-534.
2009
|
|
| 2009
|
Expanding the repertoire of modified vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
PLoS One.
4.
2009
|
|
| 2009
|
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.)..
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry.
6:122-130.
2009
|
|
| 2008
|
HDL therapy for cardiovascular diseases: The road to HDL mimetics.
Current Atherosclerosis Reports.
10:405-412.
2008
|
|
| 2007
|
Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
Journal of Virology.
81:11982-11991.
2007
|
|
| 2007
|
Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.
Virology.
367:156-167.
2007
|
|
| 2007
|
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
Journal of Lipid Research.
48:1915-1923.
2007
|
|
| 2007
|
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.
Journal of Biological Chemistry.
282:1980-1988.
2007
|
|
| 2006
|
Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
Journal of Virology.
80:8469-8481.
2006
|
|
| 2006
|
Atherosclerosis and vascular disease: Effects of peptide mimetics of apolilpoproteins.
Current Pharmaceutical Biotechnology.
7:235-240.
2006
|
|
| 2006
|
Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus Ankara enhances antiviral cellular and humoral immune responses.
Journal of Virology.
80:7676-7687.
2006
|
|
| 2006
|
Potential clinical utility of high-density lipoprotein-mimetic peptides.
Current Opinion in Lipidology.
17:440-444.
2006
|
|
| 2006
|
Synthetic peptides: Managing lipid disorders.
Current Opinion in Lipidology.
17:233-237.
2006
|
|
| 2006
|
Oral amphipathic peptides as therapeutic agents.
Expert Opinion on Investigational Drugs.
15:13-21.
2006
|
|
| 2005
|
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
2005
|
|
| 2005
|
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.
Circulation Research.
97:236-243.
2005
|
|
| 2005
|
Apolipoprotein A-I mimetic peptides - ATVB in focus
2005
|
|
| 2005
|
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice
2005
|
|
| 2005
|
Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.
Circulation.
111:3112-3118.
2005
|
|
| 2005
|
Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.
Journal of Virology.
79:4043-4054.
2005
|
|
| 2004
|
Human apolipoprotein A-I and A-I mimetic peptides: Potential for atherosclerosis reversal.
Current Opinion in Lipidology.
15:645-649.
2004
|
|
| 2004
|
Prospects for an AIDS vaccine: Three big questions, no easy answers.
Lancet Infectious Diseases.
4:397-413.
2004
|
|
| 2004
|
Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity.
Journal of Biological Chemistry.
279:26509-26517.
2004
|
|
| 2004
|
Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection.
Journal of Virology.
78:4866-4875.
2004
|
|
| 2004
|
Blockade of T cell costimulation reveals interrelated actions of CD4 + and CD8+ T cells in control of SIV replication.
Journal of Clinical Investigation.
113:836-845.
2004
|
|
| 2004
|
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice..
Circulation.
109:3215-3220.
2004
|
|
| 2003
|
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis
2003
|
|
| 2003
|
AIDS vaccine development: The long and winding road.
AIDS reviews.
5:131-139.
2003
|
|
| 2003
|
Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
Atherosclerosis.
168:229-237.
2003
|
|
| 2003
|
Association of Aortic Atherosclerosis with Cerebral β-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's Disease.
American Journal of Pathology.
163:2155-2164.
2003
|
|
| 2002
|
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Circulation.
106:1127-1132.
2002
|
|
| 2002
|
Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.
Journal of Virology.
76:4764-4772.
2002
|
|
| 2002
|
Sustained-delivery of an apolipoproteinE-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.
Journal of Controlled Release.
79:207-218.
2002
|
|
| 2002
|
Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation.
105:290-292.
2002
|
|
| 2001
|
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
Journal of Lipid Research.
42:1096-1104.
2001
|
|
| 2001
|
Toward the design of peptide mimics of antiatherogenic apolipoproteins A-I and E.
Current Science.
81:53-65.
2001
|
|
| 2001
|
Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
Journal of Lipid Research.
42:959-966.
2001
|
|
| 2001
|
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.
Journal of Lipid Research.
42:545-552.
2001
|
|
| 2000
|
Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.
Virology.
278:207-216.
2000
|
|
| 2000
|
A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples.
Journal of Lipid Research.
41:1020-1026.
2000
|
|
| 2000
|
The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
Biochemistry.
39:213-220.
2000
|
|
| 1997
|
Quantification of HDL2 and HDL3 cholesterol by the vertical auto profile-II (VAP-II) methodology.
Journal of Lipid Research.
38:2353-2364.
1997
|
|
| 1997
|
A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1.
Journal of Virology.
71:5885-5893.
1997
|
|
| 1997
|
The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans.
Clinical Science.
92:473-479.
1997
|
|
| 1996
|
Chromatographic methods for quantitation of apolipoprotein A-I.
Methods in Enzymology.
263:267-282.
1996
|
|
| 1995
|
A prospective, randomized trial of phenytoin in nonepileptic subjects with reduced HDL cholesterol
1995
|
|
| 1995
|
Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology.
Journal of Lipid Research.
36:2291-2302.
1995
|
|
| 1994
|
ApoB-100 has a pentapartite structure composed of three amphipathic α-helical domains alternating with two amphipathic β-strand domains: Detection by the computer program LOCATE
1994
|
|
| 1994
|
Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors.
Journal of Comparative Neurology.
339:3-11.
1994
|
|
| 1994
|
Gene transfer to sensory neurons using herpes virus vectors.
1994
|
|
| 1994
|
Quantification of cholesterol in all lipoprotein classes by the VAP-II method.
Journal of Lipid Research.
35:159-168.
1994
|
|
| 1994
|
The amphipathic α helix: A multifunctional structural motif in plasma apolipoproteins.
Advances in protein chemistry and structural biology.
45:303-369.
1994
|
|
| 1993
|
Cholesterol-lowering diets: Dealing with long-term adherence problems.
Cardiology Board Review.
10.
1993
|
|
| 1993
|
Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis.
Virology.
197:459-462.
1993
|
|
| 1993
|
Thyroid function and other clinical chemistry parameters in subjects eating iodine-enriched eggs.
Food and Chemical Toxicology.
31:247-251.
1993
|
|
| 1992
|
Plasma lipoproteins in hyperlipidemic subjects eating iodine-enriched eggs.
Journal of the American College of Nutrition.
11:294-303.
1992
|
|
| 1992
|
Saturated fats, cholesterol, and dietary compliance..
JAMA Internal Medicine.
152:1167-1174.
1992
|
|
| 1992
|
Analysis for cholesterol in all lipoprotein classes by single vertical ultracentrifugation of fingerstick blood and controlled-dispersion flow analysis
1992
|
|
| 1992
|
Gene transfer into mammalian central nervous system using herpes virus vectors: Extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter.
Human gene therapy. Clinical development.
3:487-499.
1992
|
|
| 1992
|
Saturated Fats, Cholesterol, and Dietary Compliance.
Archives of Internal Medicine.
152:1167-1174.
1992
|
|
| 1992
|
Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats: Correlation with physical properties
1992
|
|
| 1988
|
Ascites fluid lipoproteins in experimental nephrotic syndrome
1988
|
|
| 1985
|
Lipoproteins of ascites fluid from nephrotic rats
1985
|
|
| 1984
|
Catabolism of very low density lipoproteins in experimental nephrosis.
Journal of Clinical Investigation.
74:1375-1383.
1984
|
|
